Skip to main content
HR 4151 108th Congress House Health Administrative procedure Commerce Communicable diseases Communication in medicine Cytology Data banks Department of Health and Human Services Food and Drug Administration (FDA) Government Operations and Politics Government paperwork Governmental investigations Health facilities Health information systems Labeling Law Licenses Medical screening Medical tests Packaging

Brian Lykins Human Tissue Transplant Safety Act of 2004

Introduced: April 2, 2004 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 8, 2004
Referred to the Subcommittee on Health.
Apr 2, 2004
Referred to the House Committee on Energy and Commerce.
Apr 2, 2004
Introduced in House
 Plain-English summary Congressional Research Service

Brian Lykins Human Tissue Transplant Safety Act of 2004 - Amends the Public Health Service Act to provide for oversight by the Commissioner of Food and Drugs of entities engaged in activities relating to human tissue or human tissue-based products, requiring their registration and authorizing their inspection. Requires the reporting of any adverse incidents. Requires the Commissioner to develop a reporting mechanism and a database to store such information.

Allows the Commissioner, in an instance in which this Act is violated, to: (1) issue an order requiring any distributor of a human cell, tissue, or cellular or tissue-based product to recall or destroy such product; (2) condemn, seize, and destroy such product; (3) require a covered entity to cease the activity that resulted in the violation; or (4) suspend or revoke the registration and listing of the covered entity involved.

What's happening now April 8, 2004

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Democratic 1